Navigation Links
A new growth factor identified

Scientists have identified a growth factor that triggers blood vessel formation within the endocrine glands. In California, Dr. Jennifer of Genentech Inc. and colleagues reported their discovery of endocrine gland-derived vascular endothelial growth factor, or EG-VEGF. The finding could lead the way toward treatment for illnesses affecting these glands. The endocrine glands produce various hormones such as ovaries, testicles, pancreas, pituitary and thyroid.//

Scientists have known for several years, that a specific protein called VEGF triggers new blood vessel growth throughout the body. This has been investigated as a treatment for heart disease. Since tumors need new blood vessels in to grow, they have also sought to fight cancer by blocking VEGF's action. Unlike VEGF, the researchers also found that EG-VEGF only acts on cells that line the capillaries of the endocrine glands.

According to Dr.Napoleone Ferrara, one of the study authors, they believe that EG-VEGF was implicated in the pathogenesis of some ovarian disorders resulting in infertility, such as the polycystic ovary syndrome and an inhibitor of EG-VEGF may have therapeutic value in this condition.

He also added that the discovery also raises the possibility that other growth factors exist that act on specific tissues, such as the heart or lung or skeletal muscle, which could hold "considerable therapeutic potential.


'"/>




Page: 1

Related medicine news :

1. Anthrax drug doxycycline could stunt fetal growth
2. Zinc may enhance growth in Young sickle cell patients
3. Drug stabilizes cancer growth
4. Enzyme stimulates growth of adult stem cells
5. Mental growth in babies at risk
6. New Molecule that can stop the growth of Viruses
7. New study questions consumption of milk for bone growth
8. New study questions consumption of milk for bone growth
9. Improved height from administration of growth hormones
10. Record growth of Soya-based dairy alternatives in Europe
11. Prostate tumour growth suppressed by flavonoids
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/13/2017)... ... 13, 2017 , ... ProVest Insurance Group, a family managed ... Raleigh regions, is organizing an extended charity drive to benefit the family of ... , After struggling since birth with several health challenges, T.J. was later diagnosed ...
(Date:10/13/2017)... , ... October 13, 2017 , ... The American Board ... become its next President and Chief Executive Officer, succeeding Dr. James C. Puffer upon ... beginning July 1, 2018 until Dr. Puffer’s retirement at the end of 2018. Upon ...
(Date:10/13/2017)... ... 13, 2017 , ... Lori R. Somekh, founder of the Law Office ... of elder law and special needs planning attorneys. “Membership in ElderCounsel helps our office ... forum to network with elder law attorneys nationwide,” said Somekh. , ElderCounsel ...
(Date:10/13/2017)... , ... October 13, 2017 , ... Ellevate Network, the ... business to advocate for action towards gender equality at their inaugural Summit in New ... the globe, and reached a social audience of over 3 million. To watch the ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader ... been awarded a contract by the Center for Medicare and Medicaid Services (CMS). ... the enterprise use of Agile methodologies in a consistent and high value manner ...
Breaking Medicine News(10 mins):
(Date:10/2/2017)... , Oct. 2, 2017  Eli Lilly and Company ... results for the third quarter of 2017 on Tuesday, ... call on that day with the investment community and ... The conference call will begin at 9 a.m. ... access a live webcast of the conference call through ...
(Date:9/28/2017)... , Sept. 28, 2017 Cohen Veterans Bioscience ... the use of wearable and home sensors for real-time ... Early Signal Foundation, a nonprofit organization focused on disruptive ... provide an affordable analytical system to record and integrate ... ...
(Date:9/23/2017)... , Sept. 22, 2017 Janssen Biotech, Inc. ... response letter from the U.S. Food and Drug Administration ... of sirukumab for the treatment of moderately to severely ... additional clinical data are needed to further evaluate the ... severely active RA. ...
Breaking Medicine Technology: